-
Mashup Score: 0Wolters Kluwer Health - 2 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable…
Source: lww.comCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 1Doxycycline After Unprotected Sex Significantly Reduced STIs - 2 year(s) ago
A significant proportion of bacterial sexually transmitted infections – gonorrhea, chlamydia, or syphilis – were prevented with a dose of doxycycline after unprotected sex, according to preliminary results of a clinical trial.
Categories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 1
Original Article from The New England Journal of Medicine — Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection
Source: New England Journal of MedicineCategories: Expert Picks, Latest HeadlinesTweet
-
Mashup Score: 0Board of Directors Call for Volunteers - 2 year(s) ago
Call for Applications – HIVMA Board of Directors HIVMA is accepting applications from the membership for six open seats on the Board of Directors. The Board of Directors provides critical input, oversight and guidance to strengthen HIVMA’s programs and policy agenda. Members may submit an application from the Volunteer Opportunities page on MyIDSA (log-in required)….
Source: www.hivma.orgCategories: HIV/AIDS, Latest HeadlinesTweet
-
Mashup Score: 1Trends in the Epidemiology and Outcomes of Pneumocystis Pneumonia among Human Immunodeficiency Virus (HIV) Hospitalizations - 2 year(s) ago
Introduction: Pneumocystis Pneumonia (PCP) is a common opportunistic infection among people living with the human immunodeficiency virus (HIV). This study’s objective was to assess temporal trends in PCP epidemiology among hospitalized patients with HIV/AIDS in the US and to compare data for hospitalizations with HIV with PCP to those without PCP. Methods: The national inpatient sample (NIS) data…
Source: MDPICategories: Infectious Disease, Latest HeadlinesTweet-
Key paper: mortality amongst people with PCP is still HIGH. The groups who need PCP prophylaxis extend far beyond people with advanced HIV & cotrimoxazole remains the treatment with best evidence - thanks Prof Rob Miller. Link here: https://t.co/rjXnolpG1B #IDtwitter #HIVtwitter https://t.co/anr6u6NJdm
-
-
Mashup Score: 1International Women's Day—how can I help? - 2 year(s) ago
Globally, 51% of people with HIV are women.1 But until quite recently, women with HIV were often referred to as a special population or regarded as a subgroup in research analyses. This situation is beginning to change, possibly galvanised by the eruption of community anger around the dolutegravir teratogenicity scare.2 However, the legacy of this special status has led to persistent inequities…
Source: The Lancet HIVCategories: HIV/AIDS, Latest HeadlinesTweet
-
Mashup Score: 2Impact of PEPFAR on HIV Testing and ART Initiation - 2 year(s) ago
This findings present an opportunity for countries to critically review testing approaches to develop specific targeted HIV testing.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 0Mean Monthly Out of Pocket PrEP Costs Drop between 2020 and 2021 - 2 year(s) ago
The Affordable Care Act can remove financial barriers and increase access to PrEP, the study authors said.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 0Impact of PEPFAR on HIV Testing and ART Initiation - 2 year(s) ago
This findings present an opportunity for countries to critically review testing approaches to develop specific targeted HIV testing.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 0Mean Monthly Out of Pocket PrEP Costs Drop between 2020 and 2021 - 2 year(s) ago
The Affordable Care Act can remove financial barriers and increase access to PrEP, the study authors said.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet
Missed this from @56deanstreet 30% with newly acquired HIV has M184V if recent oral PrEP exposure vs 1% if none. We need effective PrEP that doesn't impact future treatment; my fear is IM-CAB may do just that #IDtwitter #HIVtwitter #PrEP good work 56DS!! https://t.co/Vd0aO7fKs6